SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as its community rallies around the project's consistent grind and recent milestones, fueled by a strong belief in its potential within the meme coin space on the Solana network. The community is actively discussing the coin's path to number one trending and eagerly anticipating upcoming utility releases, solidifying their conviction in Brokecoin's long-term prospects. With a focus on community engagement and transparency, Brokecoin aims to differentiate itself in the crowded altcoin market.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crowd is excited about Crow With Knife ($CAW.X), a meme token, with community members highlighting its fully circulated supply, active community, and multichain functionality across $SOL.X, BSC, $CRO.X, and $ETH.X. There is also discussion around its deflationary burn mechanism and partnerships.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as the community discusses its potential inclusion in the S&P 500, with the official announcement expected soon; the addition could lead to increased visibility and investment, though some investors are wary of a potential "sell the news" event. Community members are also weighing in on the platform's user experience, active trader focus, and comparison to competitors, while others are still referencing the company's involvement in the 2020 GME situation. Upcoming catalysts such as the Robinhood summit next week and anticipated Fed rate cuts are adding to the speculative buzz.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is trending due to its inclusion in the S&P 500, generating significant after-hours buzz and speculation about its future performance. While some community members are celebrating potential gains, others caution about overvaluation and potential insider selling. The inclusion has sparked discussions about the 'index effect' and its impact on the stock's trajectory.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors assess its potential amid the AI-driven automation landscape, with discussions focusing on its growth prospects and recent analyst ratings. Community members are debating whether the company is undervalued, citing its strong market position and partnerships, while others express concern over insider selling and the stock's historical performance. Speculation about a potential buyout is also circulating, adding to the heightened interest in PATH.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

MannKind is trending following news of an expanded collaboration with United Therapeutics to develop a second inhaled therapy, sparking enthusiasm for increased revenue potential and a strengthened partnership. The community is buzzing about the implications of this new molecule and potential future catalysts, while analysts are pointing to the expansion into pulmonary and orphan diseases as a sign of growth. Some investors speculate about a possible buyout, given the deepening relationship with United Therapeutics.

WorldFinancial

WorldFinancial (WLFI.X) is trending as the community debates its purpose and potential, particularly following a large transfer of tokens to HTX and subsequent blacklisting of Justin Sun. Some investors express concerns about a potential rug pull, while others remain optimistic due to upcoming collaborations and announcements. Discussions also revolve around the token's connection to the Trump family and its role in the broader crypto and blockchain landscape, including stablecoin adoption and potential use in DeFi.

Katapult Holdings, Inc. is an e-commerce focused financial technology company. The firm is engaged in the provision of e-commerce point-of-sale lease-purchase options for nonprime U.S. consumers. It offers its customers a lease purchase transaction processing system with no long-term obligation and options for ownership. The company was founded in August 2019 and is headquartered in Plano, TX.

Katapult Holdings Inc

KPLT is trending due to a potential turnaround and positive Q4 performance update, with gross originations growing double-digits year-over-year. Community members are discussing the low market cap relative to revenue and comparing it to other players in the BNPL space like SEZL, with some expressing optimism for a significant price increase. Some investors are also excited about the potential for a short squeeze, and a renewed credit facility.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

Mosaic ($MOS) is trending due to a mix of factors including recent Q2 earnings miss and revenue shortfalls, primarily driven by falling phosphate volumes, sparking concerns among investors. Despite improved margins, community discussions revolve around the impact of phosphate drag and potential long-term value. Analysts are weighing in with updated ratings and price targets, contributing to the stock's volatility and heightened discussion.

Didi Global, Inc. engages in the operation of mobility platforms that provides ride hailing and other related services. It operates through the following segments: China Mobility, International, and Other Initiative. The China Mobility segment consists of ride hailing, taxi hailing, chauffeur and hitch services. The International segment includes ride hailing and food delivery services in international markets, outside of China. The Other Initiatives segment mainly consists of bike and e-bike sharing, certain auto solutions, intra-city freight, community group buying, autonomous driving, and financial services. The company was founded by Wei Cheng, Qing Liu, Bo Zhang and Rui Wu on January 11, 2013 and is headquartered Beijing, China.

DiDi Global Inc - ADR

DiDi Global is surging following analyst coverage from Goldman Sachs, sparking community excitement about a potential relisting and future robotaxi ventures. Investors are closely watching for a confirmed IPO date, anticipating significant gains, while also weighing the impact of ongoing regulatory factors in China. Community members are also tracking the company's partnerships and expansion into new markets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

Cue Biopharma (CUE) delivered earnings and revenue surprises of +30.77% and +47.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates

YmAbs Therapeutics (YMAB) delivered earnings and revenue surprises of +74.07% and +5.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates

scPharmaceuticals (SCPH) delivered earnings and revenue surprises of -13.33% and -2.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates

Forecasting The Future: 4 Analyst Projections For Cue Biopharma

Latest Ratings for CUE
 DateFirmActionFromTo Nov 2020BerenbergInitiates Coverage OnBuy May 2020StifelMaintainsBuy May 2020OppenheimerMaintainsOutperform
 View More Analyst Ratings for CUE...

Cue Biopharma to Host Business Update Call and Webcast

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...

Navalign LLC Takes $66,000 Position in Cue Biopharma, Inc. (NASDAQ:CUE)

Navalign LLC bought a new stake in shares of Cue Biopharma, Inc. (NASDAQ:CUE  Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities  Exchange...

Jefferies Financial Group Begins Coverage on Cue Biopharma (NASDAQ:CUE)

Jefferies Financial Group assumed coverage on shares of Cue Biopharma (NASDAQ:CUE  Free Report) in a research report released on Wednesday, MarketBeat reports. The firm issued a buy rating and...

Cue Biopharma presenting data on lead clinical asset CUE-101 at symposium

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Cue Biopharma's Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

BOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

CUE
Cue Biopharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CUE News

CUE Cue Biopharma Inc